Targeted use of fluorescence in situ hybridization (FISH) in cytospin preparations: Results of 298 fine needle aspirates of B-cell non-Hodgkin lymphoma

Cancer Cytopathology

Volumn 118, Issue 5, 2010, Pages 250-258

  Da Cunha Santos, Gilda ^a   Ko, Hyang Mi ^a   Geddie, William R ^a   Boerner, Scott L ^a   Lai, Shui Wun ^a   Have, Cherry ^a   Kamel Reid, Suzanne ^a   Bailey, Denis ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

B cell non Hodgkin lymphoma; Cytopathology; Fine needle aspiration; Fluoresce in situ hybridization; Lymph node

Indexed keywords

IGH CCND1 FUSION PROTEIN, HUMAN; IGH MALT1 FUSION PROTEIN, HUMAN; IGH-CCND1 FUSION PROTEIN, HUMAN; IGH-MALT1 FUSION PROTEIN, HUMAN; ONCOPROTEIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CHROMOSOME ABERRATION; CYTODIAGNOSIS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; IMMUNOPHENOTYPING; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; BIOPSY, FINE-NEEDLE; CHROMOSOME ABERRATIONS; CYTODIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79952111842     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20098     Document Type: Article

References (30)

1. Chang CM, Schroeder JC, Huang WY, et al. Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. Leuk Res. 2010;34:190-195.
2. Cook JR. Paraffin section interphase fluorescence in situ hybridization in the diagnosis and classification of non-Hodgkin lymphomas. Diagn Mol Pathol. 2004;13:197-206.
3. Sreekantaiah C. FISH panels for hematologic malignancies. Cytogenet Genome Res. 2007;118:284-296.
4. Gazzo S, de Colella JM, Callet-Bauchu E. Sequential fluorescence in situ hybridisation analysis for cryptic t(11;14)(q13;q32) in mantle cell lymphoma. Br J Haematol. 2006;134:452.
5. Salaverria I, Zettl A, Bea S, et al. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol. 2007;25:1216-1222.
6. Espinet B, Salaverria I, Bea S, et al. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma. Genes Chromosomes Cancer. 2010;49:439-451.
7. Seto M, Honma K, Nakagawa M. Diversity of genome profiles in malignant lymphoma. Cancer Sci. 2010;101: 573-578.
8. Zeppa P, Vigliar E, Cozzolino I, et al. Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better? [published online ahead of print February 1, 2010] Cytopathology. PMID: 20132132.
9. Clark DP. Seize the opportunity: underutilization of fineneedle aspiration biopsy to inform targeted cancer therapy decisions. Cancer Cytopathol. 2009;117:289-297.
10. Gong Y, Caraway N, Gu J, et al. Evaluation of interphase fluorescence in situ hybridization for the t(14;18) (q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping. Cancer. 2003;99:385-393.
11. Safley AM, Buckley PJ, Creager AJ, et al. The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration. Arch Pathol Lab Med. 2004;128: 1395-1403.
12. Richmond J, Bryant R, Trotman W, Beatty B, Lunde J. FISH detection of t(14;18) in follicular lymphoma on Papanicolaou-stained archival cytology slides. Cancer. 2006;108:198-204.
13. Caraway NP, Gu J, Lin P, Romaguera JE, Glassman A, Katz R. The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens. Cancer. 2005;105:110-118.
14. Bentz JS, Rowe LR, Anderson SR, Gupta PK, McGrath CM. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material. Cancer. 2004;102:124-131.
15. Shin HJ, Thorson P, Gu J, Katz RL. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization. Diagn Cytopathol. 2003;29:61-66.
16. Caraway NP, Thomas E, Khanna A, et al. Chromosomal abnormalities detected by multicolor fluorescence in situ hybridization in fine-needle aspirates from patients with small lymphocytic lymphoma are useful for predicting survival. Cancer. 2008;114:315-322.
17. Monaco SE, Teot LA, Felgar RE, Surti U, Cai G. Fluorescence in situ hybridization studies on direct smears: an approach to enhance the fine-needle aspiration biopsy diagnosis of B-cell non-Hodgkin lymphomas. Cancer Cytopathol. 2009;117:338-348.
18. Clatch RJ, Walloch JL, Zutter MM, Kamentsky LA. Immunophenotypic analysis of hematologic malignancy by laser scanning cytometry. Am J Clin Pathol. 1996;105:744-755.
19. Clatch RJ, Walloch JL. Multiparameter immunophenotypic analysis of fine needle aspiration biopsies and other hematologic specimens by laser scanning cytometry. Acta Cytol. 1997;41:109-122.
20. Al-Za'abi AM, Geddie WB, Boerner SL. Equivalence of laser scanning cytometric and flow cytometric immunophenotyping of lymphoid lesions in cytologic samples. Am J Clin Pathol. 2008;129:780-785.
21. Jiang F, Lin F, Price R, et al. Rapid detection of IgH/ BCL2 rearrangement in follicular lymphoma by interphase fluorescence in situ hybridization with bacterial artificial chromosome probes. J Mol Diagn. 2002;4:144-149.
22. Zhang S, Abreo F, Lowery-Nordberg M, Veillon DM, Cotelingam JD. The role of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis and classification of lymphoproliferative disorders on fine-needle aspiration. Cancer Cytopathol. 2010;118:105-112.
23. Gu K, Chan WC, Hawley RC. Practical detection of t(14;18)(IgH/BCL2) in follicular lymphoma. Arch Pathol Lab Med. 2008;132:1355-1361.
24. Snuderl M, Kolman OK, Chen YB, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large Bcell lymphoma. Am J Surg Pathol. 2010;34:327-340.
25. Tomita N, Tokunaka M, Nakamura N, et al. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica. 2009;94:935-943.
26. Einerson RR, Kurtin PJ, Dayharsh GA, Kimlinger TK, Remstein ED. FISH is superior to PCR in detecting t(14;18) (q32;q21)-IgH/bcl-2 in follicular lymphoma using paraffin-embedded tissue samples. Am J Clin Pathol. 2005;124:421-429.
27. Ventura RA, Martin-Subero JI, Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn. 2006;8:141-151.
28. Buno I, Nava P, Alvarez-Doval A, Alvarez-Rodriguez F, Diez-Martin JL, Menarguez J. Lymphoma associated chromosomal abnormalities can easily be detected by FISH on tissue imprints. An underused diagnostic alternative. J Clin Pathol. 2005;58:629-633.
29. Cuneo A, Bigoni R, Rigolin GM, et al. Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. Blood. 1999;93:1372-1380.
30. Katzenberger T, Kienle D, Stilgenbauer S, et al. Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis. Br J Haematol. 2008;142:538-550.